The Digital Diabetes Market is expected to grow at a CAGR of 21.7%from 2018 to 2025 to reach $12.03 billion by 2025. Factors such as rising number of diabetic patients, increasing penetration of smartphones, technological advancement in diabetes devices, and growing funding for diabetes are driving the growth of this market. However, high cost of devices and poor reimbursement scenario is expected to hinder the growth of this market in the coming years.
Rising number of diabetes fuels the growth of the global digital diabetes market
Diabetes is attaining epidemic proportions and digital health companies are fighting back with innovative solutions. Approximately, one in 11 adults across the globe has diabetes attributing to 425 million people, worldwide. As the cases of diabetes are growing so is the digital diabetes market. Over the last few years, the digital diabetes care market has substantially progressed. If these trends continue, by 2045, 693 million people aged between 18-99 years, or 629 million of people aged between 20-79 years, will have diabetes. Globally, diabetes results in $727 billion of healthcare expenditure, which corresponds to one for every eight dollars spent on healthcare. Thus, rising number of diabetic patients across the globe and increasing demand for better ways to manage the disease is expected to drive the adoption of innovative diabetes devices, software, and apps among patients over the coming years, thereby driving the growth of the digital diabetes market.
Increasing funding for diabetes management software and apps drives the market growth
In recent years, number of pharma companies and research organizations have increased funding for digital diabetes care app’s and software development. For instance,
- In 2015, mySugar raised $4.8 million from Roche Ventures and iSeed Ventures to scale up its user base in the US and other countries.
- In 2017, Glooko, the leader in diabetes data management, announced $35 million in new funding to accelerate growth, expand international presence, and deepen expertise in data analytics.
- In 2017, Wellthy Therapeutics Pvt Ltd, which operates a mobile-based diabetes management platform, raised an undisclosed sum from early-stage investor GrowX Ventures.
- In 2018, Livongo Health raised $105 million more as the business of mobile monitoring technology to manage chronic conditions attracts big names in technology, health insurance and the investor community.
- In 2018, Fit4D, a New York City-based diabetes management app, announced $4 million funding to expand its innovation efforts.
The rising number of funding from companies and organizations is expected to drive the adoption of digital diabetes devices which in turn is expected to drive the growth of this market in coming years.
Click here to: Get Free Sample Pages of this Report
Key findings in the global digital diabetes market study:
Devices segment dominates digital diabetes market during the forecast period
The devices segment accounted for the largest share in digital diabetes market in 2018. This market is expected to grow at a CAGR of 21.5% in the forecast period mainly attributed to growing diabetic population, increasing adoption of diabetes devices, and growing awareness about diabetes in emerging countries.
CGM Systems is expected to dominate the digital diabetes devices market
CGM systems accounted for the largest share of digital diabetes devices market, by type. Increasing adoption of CGM systems, development of advanced CGM systems, and favorable government policies in developed countries promoting adoption of CGM systems are the key factors contributing to the largest share and highest growth of this segment.
Home Care is the largest end user segment for digital diabetes market
Over the past few years, the development and adoption of home care devices has increased. In addition, growing focus of companies to increase awareness about diabetes and diabetes devices & apps are further driving the adoption in home care settings. In 2018, home care segments accounted for the largest share of the global digital diabetes market.
Asia Pacific: Fastest growing regional market
Asia Pacific expected to register the fastest growth during forecast period. Several factors, such as high pool of diabetic patients, increasing healthcare expenditure, and growing focus of key players towards this region are expected to propel the growth of this market. Increasing disposable income and growing awareness on diabetes and associated diseases are further expected to drive the growth of this regional segment.
Digital Diabetes Market Key Players
The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3 years (2015-2018). The key players in the global digital diabetes market are Lifescan, Roche, Medtronic, Ascensia Diabetes Care, Tandem Diabetes Care, Dexcomm, SocialDiabetes, One Drop, H2 Inc., Dottli Oy, Abbott Laboratories, Ypsomed holding AG, ARKRAY Inc., and Insulet Corporation among many others.
Scope of Digital Diabetes Market Report:
Digital Diabetes Market by Product
- Devices
- Self-Monitoring Blood Glucose (SMBG) Systems
- Continuous Glucose Monitoring (CGM) Systems
- Smart Insulin Pumps
- Traditional
- Tubeless/Patch Pump
- Closed Loop Pump
- Smart Insulin Pens
- Diabetes Management Software
- Diabetes Management Apps
Digital Diabetes Market by End User
- Home care
- Hospitals and Clinics
Digital Diabetes Market by Geography
- North America
- Europe
- Germany
- Spain
- France
- U.K.
- Italy
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East and Africa
Key questions answered in the report:
Smart glucose meters dominated the digital diabetes market
- Which factors contribute to better acceptance of smart glucose meters as compared to other diabetes management devices?
- Which geographic segment is expected to register highest growth in the smart glucose meters market and other product segments?
- What are the factors driving greater demand for digital diabetes management products and services?
North America favors both regional and local manufacturers that compete in multiple segments
- Who are the top market players and what strategies they adopt to gain majority of the market share?
- What strategies should emerging/ developing companies adopt to enter/compete effectively in this market?
- What strategies local players have adopted to compete with the global market leaders?
- What are the major drivers, restraints, and opportunities in the digital diabetes market?
- Who are the major players in various countries and what share of the market do they hold?
- What are the geographical trends and high growth regions/ countries?
Recent strategic developments taken place in the digital diabetes market
- What technological advancements have taken place in this industry?
- Which companies are recently merged/acquired by prominent players in this market and how will these unions affect the competitive landscape of the digital diabetes market?
- Who are the major players in the global digital diabetes market and what shares of the market do they hold?
- What are the local emerging players in this market and how do they compete with the global players?
